CellaraRx Therapeutics Information

🧠 About Us: CellaraRx is a healthtech company building next-generation AI solutions to transform how cancer therapies are developed, tested, and delivered. We leverage single-cell RNA sequencing and advanced machine learning to predict how individual patients will respond to specific treatments—enabling truly personalized medicine and dramatically improving clinical trial outcomes. Today, over 90% of drugs fail in clinical trials, often due to patient heterogeneity and lack of predictive insight. CellaraRx addresses this challenge by turning complex biological data into actionable intelligence for researchers, clinicians, and pharmaceutical companies. 🚀 Our Mission: To make drug discovery smarter, faster, and more equitable by ensuring the right therapies reach the right patients. 🔬 What We Do: Predict patient response to cancer therapies using AI. Analyze single-cell omics data for precision oncology Enable smarter, data-driven clinical trial design Reduce drug development costs and failure rates 💡 Our Vision: A future where every patient receives the most effective treatment from day one—and no promising therapy fails due to avoidable uncertainty.